Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Kilroy Realty | KRC | Oct 11, 2024 | 38.88 | +2.18 |
Kimball Electronics | KE | Oct 11, 2024 | 17.65 | +2.98 |
Kimbell Royalty Partners LP Units | KRP | Oct 11, 2024 | 16.44 | +0.67 |
Kimberly-Clark | KMB | Oct 11, 2024 | 142.25 | +0.84 |
Kimco Realty | KIM | Oct 11, 2024 | 23.18 | +1.40 |
Kimco Realty L Pref | KIM-L | Oct 11, 2024 | 23.30 | -1.10 |
Kimco Realty M Pref | KIM-M | Oct 11, 2024 | 23.89 | -2.05 |
Kimco Realty Pref ADR | KIM-N | Oct 11, 2024 | 59.33 | -0.79 |
Kinder Morgan | KMI | Oct 11, 2024 | 24.70 | +4.13 |
Kindly MD | KDLY | Oct 11, 2024 | 1.39 | +8.59 |
Kineta | KA | Oct 11, 2024 | 0.83 | 0.00 |
Kinetik A | KNTK | Oct 11, 2024 | 49.69 | +2.37 |
Kingsoft Cloud ADR | KC | Oct 11, 2024 | 3.23 | +1.89 |
Kingstone Companies | KINS | Oct 11, 2024 | 9.84 | +4.24 |
Kingsway Financial Services | KFS | Oct 11, 2024 | 8.62 | +2.38 |
Kiniksa Pharmaceuticals | KNSA | Oct 11, 2024 | 26.56 | +4.20 |
Kinross Gold | KGC | Oct 11, 2024 | 9.82 | -0.30 |
Kinsale Capital Group | KNSL | Oct 11, 2024 | 469.56 | +0.81 |
Kintara Therapeutics | KTRA | Oct 11, 2024 | 0.18 | +0.91 |
Kiora Pharmaceuticals | KPRX | Oct 11, 2024 | 3.44 | +5.52 |
Kirby | KEX | Oct 11, 2024 | 125.02 | +3.14 |
Kirklands | KIRK | Oct 11, 2024 | 2.06 | +3.52 |
Kite Realty Group Trust | KRG | Oct 11, 2024 | 25.59 | +0.31 |
KKR & Co | KKR | Oct 11, 2024 | 135.59 | +1.86 |
KKR Income Opportunities Fund | KIO | Oct 11, 2024 | 14.72 | -1.87 |
KKR Real Estate Finance Trust | KREF | Oct 11, 2024 | 11.63 | +0.95 |
KKR Real Estate Finance Trust A Pref | KREF-A | Oct 11, 2024 | 21.08 | +0.19 |
KLA | KLAC | Oct 11, 2024 | 803.73 | +0.72 |
Klaviyo | KVYO | Oct 11, 2024 | 37.00 | +1.37 |
KLD 400 Social Index Ishares | DSI | Oct 11, 2024 | 109.45 | +0.44 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.